跳至主要内容
临床试验/NCT05477836
NCT05477836已完成不适用

Feasibility and Safety of MiWEndo-assisted Colonoscopy:Pilot Study

MiWEndo Solutions S.L.1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2022年10月18日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
15
试验地点
1
主要终点
Number of mural injuries

研究概览

简要总结

The study involves the planned use of a new microwave-based device during colonoscopy procedures in a small group of patients to assess the preliminary safety of its use and lack of normal clinical practice modification. The device is a final design version, which has been previously tested in several preclinical studies, including: phantom studies, an ex vivo study with human tissues, and an in vivo study with animal model (pig).

详细描述

This study is designed as a single-center prospective, non-comparative, first in human pilot safety and feasibility study with few patients, whereby data will be subject to an analytical description, rather than to a statistical treatment (refer to Statistical design and analysis).

In this study the principal aim is to assess the clinical safety of the device and the feasibility of its use in assisted colonoscopy. Relevant claims to verify in this study are that the device can be used without ADEs, without any change in the current clinical practice, as well as without any major difficulty by the endoscopist, neither in the preparation nor in the use of the device during exploration.

In addition, the study aims to gather real clinical data with the use of the device to optimise the processing software that will be key to demonstrate MiWEndo's performance on a subsequent clinical investigation (pivotal study).

Consequently, principal and secondary objectives of this investigation, are:

  • Principal objectives:

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women older than 50 years referred for a diagnostic or surveillance colonoscopy and having signed the Informed Consent Form.

排除标准

  • Patients at a high risk of having major complications as perforation or hemorrhage or in whom the possibility of performing a complete colonoscopy is reduced, including: patients with known colonic strictures, total colectomy, acute diverticulitis, inflammatory bowel disease, suspected or proven lower gastrointestinal bleeding, non-correctable coagulopathy or anticoagulant/clopidogrel therapy during procedure, inadequate bowel cleansing or previous incomplete colonoscopy.
  • ASA-IV patients
  • Urgent colonoscopy

结局指标

主要结局

Number of mural injuries

时间窗: During the procedure

To assess the safety of MiWEndo colonoscopy according to the Sydney classification for deep mural injuries (DMI)

Rate of cecal intubation

时间窗: During the procedure

To assess the feasibility of performing a complete colonoscopy using the MiWEndo System. This parameter will be measured as complete colonoscopy (yes/no).

Number of incidents and adverse events

时间窗: During the procedure and up to 2 weeks after

To assess the safety of MiWEndo colonoscopy using the lexicon proposed by the American Society of Gastrointestinal Endoscopy (ASGE).

Length of colon explored

时间窗: During the procedure

In case cecum could not be reached, the distance will be measured (in cm).

次要结局

  • Total time for completing the procedure(Immediately after the procedure)
  • Time for reaching the cecum (or maximum explored colon length)(During the procedure)
  • Perception of difficulty(Immediately after the procedure)
  • Patients' comfort(Immediately after the procedure and 2 weeks after)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验